Emcure Pharmaceuticals Ltd.
EMCURE
Rankning i aktier
#4306
Emcure Pharmaceuticals Limited is committed to providing high-quality,... Emcure Pharmaceuticals Limited is committed to providing high-quality, cost-effective healthcare solutions to a global market. The company boasts a diverse product lineup spanning numerous medical fields, such as women's health (gynecology), anti-infectives, pain relief, nutritional supplements (vitamins, minerals, and nutrients), hematology, oncology, respiratory treatments, HIV antivirals, gastrointestinal remedies, anti-diabetics, neurological medications, and cardiovascular therapies. Notable brand names under their umbrella include Orofer XT, Tenectase, Pause, Metpure XL, Vylda, Vitanova, and Proxym. Founded in 1981, Emcure Pharmaceuticals Limited is headquartered in Pune, India.
Aktiekurs
$19.06
Marknadsvärde
$3.62B
Förändring (1 dag)
-1.83%
Förändring (1 år)
20.50%
Land
IN
Handel Emcure Pharmaceuticals Ltd. (EMCURE)
Kategori
Healthcare
Historik för aktiesplit för Emcure Pharmaceuticals Ltd. (EMCURE)
Aktien Emcure Pharmaceuticals Ltd. (symbol: EMCURE) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Oct 22, 2026.
En EMCURE-aktie köpt före Oct 22, 2026 motsvarar nu 0 EMCURE-aktier.
Den senaste spliten skedde den Oct 22, 2026.
En EMCURE-aktie köpt före Oct 22, 2026 motsvarar nu 0 EMCURE-aktier.
Lista över aktiesplitar
| År | Split | Multipel | Kumulativ multipel |
|---|---|---|---|
| Inte tillräckligt med data för de angivna datumen. | |||
Aktiesplitar för liknande företag eller konkurrenter
| Företag | Antal aktiesplitar | Kumulativ multipel | Land |
|---|---|---|---|
| 0 | - |
DE
|
|
| 0 | - |
DE
|
|
| 0 | - |
JP
|
|
| 0 | - |
CH
|
|
| 5 | x119 |
IN
|
